Skip to content

ARKOPHARMA BELUX: what changed

What changed

ARKOPHARMA BELUX

BE 0401.962.852
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€68,891
2023 · €399,596-€330,704
Equity
€2.0m
2023 · €1.9m+€68,891
Cash
€136,719
2023 · €86,880+€49,839
Balance sheet total
€5.3m
2023 · €5.4m-€85,501

Largest movements

2023 to 2024
Assets
  • Stocks and contracts -€630,808

    down €630,808 (-24.0%), from €2.6m to €2.0m

  • Receivables within one year +€542,075

    up €542,075 (+33.0%), from €1.6m to €2.2m

    of which Other amounts receivable: +€579,289

  • Deferred charges and accrued income -€56,037

    down €56,037 (-79.2%), from €70,716 to €14,680

Equity and liabilities
  • Trade debts -€404,527

    down €404,527 (-16.1%), from €2.5m to €2.1m

  • Other debts +€284,473

    up €284,473 (+54.5%), from €522,002 to €806,474

  • Profit (loss) carried forward +€83,515

    up €83,515 (+5.4%), from €1.5m to €1.6m

Income statement
  • Goods and materials +€192,504

    up €192,504 (+4.7%), from €4.1m to €4.3m

    of which Change in stocks: decrease (increase): +€1.2m

  • Staff costs -€149,533

    down €149,533 (-7.5%), from €2.0m to €1.8m

  • Services and other goods -€103,606

    down €103,606 (-5.0%), from €2.1m to €2.0m

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 €399,596
Turnover +€64,712
Other operating income -€17,490
Goods and materials -€192,504
Services and other goods +€103,606
Staff costs +€149,533
Depreciation -€11,997
Write-downs -€56,595
Other operating charges -€2,984
Other operating items -€348,067
Financial income -€146
Financial charges -€38,965
Taxes +€20,191
Result 2024 €68,891
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€194,906
Investment -€136,657
Financing -€8,409
Cash 2023 €86,880
Net result for the year +€68,891
Depreciation +€127,227
Stocks and contracts +€630,808
Receivables within one year -€542,075
Deferred charges and accrued income +€56,037
Provisions -€4,847
Trade debts -€404,527
Tax, wage and social debts -€21,103
Other debts +€284,473
Accrued charges and deferred income +€22
Investment in fixed assets (net) -€136,657
Debts after one year -€8,409
Cash 2024 €136,719
brings cash intakes cash out
Every line side by side 74 lines
Line Code 2023 2024 Change %
Total assets 20/58 €5,410,513 €5,325,013 -€85,501 -1.6%
Fixed assets 21/28 €977,623 €987,054 +€9,430 +1.0%
Tangible fixed assets 22/27 €977,623 €987,054 +€9,430 +1.0%
Land and buildings 22 €786,823 €839,883 +€53,060 +6.7%
Furniture and vehicles 24 €128,430 €93,210 -€35,220 -27.4%
Leasing and similar rights 25 €62,370 €53,961 -€8,409 -13.5%
Financial fixed assets 28 €0 - =
Affiliated companies 280/1 €0 - =
Participating interests 280 €0 - =
Current assets 29/58 €4,432,890 €4,337,959 -€94,931 -2.1%
Stocks and contracts in progress 3 €2,630,367 €1,999,558 -€630,808 -24.0%
Stocks 30/36 €2,630,367 €1,999,558 -€630,808 -24.0%
Goods purchased for resale 34 €2,630,367 €1,999,558 -€630,808 -24.0%
Amounts receivable within one year 40/41 €1,644,927 €2,187,002 +€542,075 +33.0%
Trade receivables 40 €941,192 €903,978 -€37,215 -4.0%
Other amounts receivable 41 €703,735 €1,283,024 +€579,289 +82.3%
Cash at bank and in hand 54/58 €86,880 €136,719 +€49,839 +57.4%
Deferred charges and accrued income 490/1 €70,716 €14,680 -€56,037 -79.2%
Total equity and liabilities 10/49 €5,410,513 €5,325,013 -€85,501 -1.6%
Equity 10/15 €1,912,108 €1,981,000 +€68,891 +3.6%
Contributions 10/11 €125,000 €125,000 = 0.0%
Capital 10 €125,000 €125,000 = 0.0%
Issued capital 100 €125,000 €125,000 = 0.0%
Reserves 13 €245,886 €231,262 -€14,623 -5.9%
Non-distributable reserves 130/1 €12,500 €12,500 = 0.0%
Legal reserve 130 €12,500 €12,500 = 0.0%
Tax-exempt reserves 132 €159,990 €145,367 -€14,623 -9.1%
Distributable reserves 133 €73,396 €73,396 = 0.0%
Profit (loss) carried forward 14 €1,541,223 €1,624,737 +€83,515 +5.4%
Provisions and deferred taxes 16 €82,928 €78,080 -€4,847 -5.8%
Provisions for liabilities and charges 160/5 €10,496 €10,496 = 0.0%
Other liabilities and charges 164/5 €10,496 €10,496 = 0.0%
Deferred taxes 168 €72,432 €67,584 -€4,847 -6.7%
Amounts payable 17/49 €3,415,477 €3,265,933 -€149,545 -4.4%
Amounts payable after more than one year 17 €50,457 €42,047 -€8,409 -16.7%
Financial debts 170/4 €50,457 €42,047 -€8,409 -16.7%
Leasing and similar obligations 172 €50,457 €42,047 -€8,409 -16.7%
Amounts payable within one year 42/48 €3,364,712 €3,223,554 -€141,158 -4.2%
Current portion of amounts payable after more than one year 42 €8,409 €8,409 = 0.0%
Trade debts 44 €2,506,086 €2,101,560 -€404,527 -16.1%
Suppliers 440/4 €2,506,086 €2,101,560 -€404,527 -16.1%
Taxes, remuneration and social security 45 €328,214 €307,111 -€21,103 -6.4%
Taxes 450/3 €79,667 €82,879 +€3,212 +4.0%
Remuneration and social security 454/9 €248,548 €224,232 -€24,316 -9.8%
Other amounts payable 47/48 €522,002 €806,474 +€284,473 +54.5%
Accrued charges and deferred income 492/3 €309 €331 +€22 +7.2%
Operating income 70/76A €8,908,635 €8,607,790 -€300,845 -3.4%
Turnover 70 €8,516,593 €8,581,305 +€64,712 +0.8%
Other operating income 74 €43,975 €26,485 -€17,490 -39.8%
Non-recurring operating income 76A €348,067 - -€348,067
Operating charges 60/66A €8,340,795 €8,351,735 +€10,940 +0.1%
Goods for resale, raw materials and consumables 60 €4,075,964 €4,268,468 +€192,504 +4.7%
Purchases 600/8 €4,781,383 €3,739,255 -€1.0m -21.8%
Change in stocks: decrease (increase) 609 -€705,419 €529,213 +€1.2m
Services and other goods 61 €2,072,787 €1,969,181 -€103,606 -5.0%
Remuneration, social security and pensions 62 €1,999,373 €1,849,840 -€149,533 -7.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €115,230 €127,227 +€11,997 +10.4%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €56,375 €112,970 +€56,595 +100%
Other operating charges 640/8 €21,066 €24,050 +€2,984 +14.2%
Operating profit (loss) 9901 €567,840 €256,055 -€311,785 -54.9%
Financial income 75/76B €146 - -€146
Recurring financial income 75 €146 - -€146
Other financial income 752/9 €146 - -€146
Financial charges 65/66B €100,364 €139,329 +€38,965 +38.8%
Recurring financial charges 65 €100,364 €139,329 +€38,965 +38.8%
Debt charges 650 €60,584 €37,690 -€22,894 -37.8%
Other financial charges 652/9 €39,780 €101,638 +€61,858 +156%
Profit (loss) for the period before taxes 9903 €467,622 €116,726 -€350,896 -75.0%
Transfer from deferred taxes 780 €4,847 €4,847 = 0.0%
Income taxes 67/77 €72,873 €52,682 -€20,191 -27.7%
Taxes 670/3 €72,873 €52,682 -€20,191 -27.7%
Profit (loss) for the period 9904 €399,596 €68,891 -€330,704 -82.8%
Transfer from tax-exempt reserves 789 €14,623 €14,623 = 0.0%
Profit (loss) for the period to be appropriated 9905 €414,219 €83,515 -€330,704 -79.8%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.